These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23036629)
21. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation. Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873 [TBL] [Abstract][Full Text] [Related]
22. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial). Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976 [TBL] [Abstract][Full Text] [Related]
23. Implantation of left atrial appendage occlusion devices and complex appendage anatomy: the importance of transesophageal echocardiography. Jorgensen J; Palmer S; Kalogeropoulos A; Arita T; Block P; Martin R; Lerakis S Echocardiography; 2007 Feb; 24(2):159-61. PubMed ID: 17313547 [TBL] [Abstract][Full Text] [Related]
24. Left atrial catheter ablation subsequent to Watchman® left atrial appendage device implantation: a single centre experience. Walker DT; Phillips KP Europace; 2015 Sep; 17(9):1402-6. PubMed ID: 25999186 [TBL] [Abstract][Full Text] [Related]
25. [Percutaneous closure of the left atrial appendage for stroke prevention]. Loupis AM; De Backer O; Ihlemann N; Rosenberg TS; Franzen OW; Søndergaard L Ugeskr Laeger; 2014 Sep; 176(38):. PubMed ID: 25294196 [TBL] [Abstract][Full Text] [Related]
26. Computed Tomography-X Ray Fusion in Left Atrial Appendage Closure. Barreiro-Pérez M; Cruz-González I; Sánchez PL Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):867. PubMed ID: 28274702 [No Abstract] [Full Text] [Related]
27. Left atrial appendage closure. Lin AC; Knight BP Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302 [TBL] [Abstract][Full Text] [Related]
28. Left atrial appendage occlusion eliminates the need for warfarin. Holmes DR; Schwartz RS Circulation; 2009 Nov; 120(19):1919-26; discussion 1926. PubMed ID: 19901202 [No Abstract] [Full Text] [Related]
29. Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation. Price MJ Prog Cardiovasc Dis; 2018; 60(4-5):542-549. PubMed ID: 29339165 [TBL] [Abstract][Full Text] [Related]
30. Left atrial appendage occlusion does not eliminate the need for warfarin. Whitlock RP; Healey JS; Connolly SJ Circulation; 2009 Nov; 120(19):1927-32; discussion 1932. PubMed ID: 19901203 [No Abstract] [Full Text] [Related]
31. Percutaneous left atrial appendage closure for stroke prevention in India: The beginning of a new era. Aminian A; Khalil G; Tzikas A Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S4-6. PubMed ID: 26688151 [No Abstract] [Full Text] [Related]
32. Left Atrial Appendage Closure for Stroke Prevention: Devices, Techniques, and Efficacy. Iskandar S; Vacek J; Lavu M; Lakkireddy D Cardiol Clin; 2016 May; 34(2):329-51. PubMed ID: 27150181 [TBL] [Abstract][Full Text] [Related]
33. Self-expandable device for percutaneous closing of left atrial appendage with organized thrombus in a patient with permanent atrial fibrillation. Pak HN; Shim CY; Kim JS; Park JW; Jang Y Can J Cardiol; 2013 Oct; 29(10):1329.e1-1329.e3. PubMed ID: 23228490 [TBL] [Abstract][Full Text] [Related]
34. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device. Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552 [TBL] [Abstract][Full Text] [Related]
35. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure. Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117 [TBL] [Abstract][Full Text] [Related]
36. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation. Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964 [TBL] [Abstract][Full Text] [Related]
37. Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation. Cingolani E; Stevens S; Shehata M; Diamond GA; Kaul S Arch Intern Med; 2011 Oct; 171(18):1670-2. PubMed ID: 21746999 [No Abstract] [Full Text] [Related]
38. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation. Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462 [TBL] [Abstract][Full Text] [Related]
39. Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Briceno DF; Villablanca P; Cyrille N; Massera D; Bader E; Manheimer E; Aagaard P; Ferrick K; Gross J; Kim SG; Krumerman A; Palma E; Guttenplan N; Romero J; Fisher J; Garcia M; Natale A; Di Biase L Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1057-64. PubMed ID: 26226997 [TBL] [Abstract][Full Text] [Related]